Last reviewed
Introduction
Modified peptides present unique analytical challenges beyond standard linear sequences. This guide covers testing considerations for various peptide modifications commonly encountered in research and drug development.
Types of Peptide Modifications
N-Terminal Modifications
Acetylation (Ac-)
- Protects against aminopeptidases
- Mass increase: +42 Da
- HPLC: Typically more retained (more hydrophobic)
Formylation (For-)
- Mass increase: +28 Da
- Often synthesis artifact
PEGylation
- Extends half-life
- Variable mass increase
- May require SEC or specialized HPLC
C-Terminal Modifications
Amidation (-NH2)
- Protects against carboxypeptidases
- Mass change: -1 Da (loss of OH, gain of NH2)
- Very common modification
Esterification
- Prodrug strategy
- Mass increase depends on alcohol
Side Chain Modifications
Phosphorylation
- Mass increase: +80 Da (HPO3)
- Affects HPLC retention significantly
- MS: Characteristic neutral loss of 98 Da
Glycosylation
- Complex mass increases
- Heterogeneity common
- Specialized methods required
Lipidation
- Fatty acid attachment
- Greatly increases hydrophobicity
- May require organic solvents
Cyclic Peptides
Analytical Challenges
Structural Verification:
- Must confirm cyclization occurred
- Distinguish from linear precursor
- Multiple cyclization modes possible
HPLC Behavior:
- Often different retention than linear form
- May have unusual peak shapes
- Reference standard essential
Testing Approach
- MW 18 Da less than linear (loss of H2O)
- MS/MS fragmentation pattern differs
- May need specialized fragmentation
NMR:
- Confirms cyclic structure
- Can identify cyclization site
- Useful for diastereomer identification
Stapled Peptides
What Are Stapled Peptides?
Hydrocarbon staples lock α-helical conformation:
- Enhanced cell penetration
- Improved stability
- Altered binding properties
Analytical Considerations
HPLC:
- Staple increases hydrophobicity
- May require method optimization
- Monitor for incomplete stapling
Mass Spectrometry:
- Confirm staple mass addition
- Verify staple location (MS/MS)
- Check for by-products
Circular Dichroism:
- Confirms α-helical content
- Quantifies helicity improvement
- Important for activity correlation
Peptide Conjugates
Antibody-Peptide Conjugates
Analysis involves:
- Peptide release and quantitation
- Drug-to-antibody ratio (DAR)
- Conjugation site identification
Peptide-Drug Conjugates
Key tests:
- Overall purity by HPLC
- Free drug quantitation
- Linker integrity
- Release kinetics (if cleavable)
Fluorescent/Labeled Peptides
Considerations:
- Label may affect chromatography
- Fluorescence detection options
- Verify label attachment site
